Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
Hepatus Series
2021

Share:

Hepatus Series

Non-invasive fibrosis evaluation system

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

This device series opens up a new era for non-invasive liver disease diagnosis. It is suitable for the quantitative diagnosis of liver fibrosis and fatty liver caused by various chronic liver diseases. It supports early detection, diagnosis, treatment, and rehabilitation of various chronic liver diseases. Recommend by global liver disease guidelines, non-invasive quantitative analysis of fibrosis is the first step in chronic liver disease assessment.

Date of Launch
2020
Development Time
25 - 36 months
Target Regions
Asia, Europe, North America, South America
Target Groups
Consumer / User

RELATED PROJECTS